Analyst Consensus ?
ConsensusBuy27 ratings
Bullish2696.3%
Neutral13.7%
Bearish00.0%
FN2 Earnings Intelligence
Axsome Therapeutics, Inc. analyst ratings
Axsome Therapeutics, Inc. (AXSM) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$137Current
$25Low
$227.86Average
$380High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 5, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| UBS | Buy | Buy | Maintain | Nov 3, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Nov 3, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Nov 3, 2026 |
| Guggenheim | Buy | Buy | Maintain | Nov 3, 2026 |
| Baird | Outperform | Outperform | Maintain | Nov 3, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Oct 26, 2026 |
| Deutsche Bank | Buy | Buy | Maintain | Sep 29, 2026 |
| Truist Securities | Buy | Buy | Maintain | Sep 23, 2026 |
| HC Wainwright & Co. | Buy | Buy | Maintain | Aug 31, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Aug 12, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Aug 11, 2026 |
| Needham | Buy | Buy | Maintain | Aug 11, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jun 17, 2026 |
| Jefferies | Buy | Buy | Maintain | May 4, 2026 |
| Leerink Partners | Outperform | Outperform | Maintain | Jan 28, 2026 |
| B of A Securities | Buy | Buy | Maintain | Aug 5, 2025 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Feb 19, 2025 |
| Citigroup | Buy | Buy | Maintain | May 7, 2024 |
| BTIG | Buy | Buy | Maintain | Dec 23, 2022 |
| SVB Leerink | Outperform | Outperform | Maintain | Nov 29, 2022 |
| Loop Capital | Buy | Buy | Maintain | Nov 1, 2022 |
| Cowen & Co. | Outperform | Outperform | Maintain | Jun 29, 2022 |
| Berenberg | Buy | Buy | Maintain | Jun 10, 2021 |
| H.C. Wainwright | Buy | Buy | Maintain | Dec 30, 2019 |
| William Blair | Outperform | Outperform | Maintain | Sep 18, 2019 |
| BTIG Research | Buy | Buy | Maintain | May 19, 2017 |
| Brean Capital | Buy | Buy | Maintain | Dec 17, 2015 |
Named analyst price targets
Upside is calculated against the persisted current price $137. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Guggenheim | Yatin Suneja | $250 | $142.54 | +82.5% | Nov 3, 2026 |
| UBS | Ashwani Verma | $239 | $136.01 | +74.5% | Nov 3, 2026 |
| Piper Sandler | Analyst unavailable | $238 | $145.04 | +73.7% | Oct 26, 2026 |
| RBC Capital | Analyst unavailable | $295 | $168.6 | +115.3% | Oct 8, 2026 |
| Deutsche Bank | Analyst unavailable | $267 | $188.66 | +94.9% | Sep 29, 2026 |
| Morgan Stanley | Analyst unavailable | $247 | $198.57 | +80.3% | Sep 25, 2026 |
| Truist Financial | Srikripa Devarakonda | $285 | $203.1 | +108.0% | Sep 23, 2026 |
| Mizuho Securities | Graig Suvannavejh | $316 | $215.77 | +130.7% | Aug 12, 2026 |
| RBC Capital | Leonid Timashev | $297 | $219 | +116.8% | Aug 11, 2026 |
| Morgan Stanley | Analyst unavailable | $251 | $221.21 | +83.2% | Aug 11, 2026 |
| Needham | Ami Fadia | $268 | $220.89 | +95.6% | Aug 11, 2026 |
| Guggenheim | Analyst unavailable | $275 | $220.89 | +100.7% | Aug 11, 2026 |
| Wells Fargo | Analyst unavailable | $256 | $220.89 | +86.9% | Aug 11, 2026 |
| BMO Capital | Malcolm Hoffman | $310 | $221.64 | +126.3% | Jul 20, 2026 |
| RBC Capital | Leonid Timashev | $304 | $242.6 | +121.9% | Jul 7, 2026 |
| Jefferies | Andrew Tsai | $380 | $246.34 | +177.4% | Jun 11, 2026 |
| Deutsche Bank | David Hoang | $280 | $230.1 | +104.4% | May 5, 2026 |
| Morgan Stanley | Analyst unavailable | $242 | $230.11 | +76.6% | May 5, 2026 |
| Needham | Analyst unavailable | $267 | $230.63 | +94.9% | May 5, 2026 |
| RBC Capital | Leonid Timashev | $302 | $231 | +120.4% | May 5, 2026 |
| Robert W. Baird | Brian Skorney | $246 | $223.7 | +79.6% | May 5, 2026 |
| H.C. Wainwright | Analyst unavailable | $290 | $223.7 | +111.7% | May 5, 2026 |
| Oppenheimer | Analyst unavailable | $280 | $223.34 | +104.4% | May 4, 2026 |
| Guggenheim | Yatin Suneja | $260 | $227.31 | +89.8% | May 4, 2026 |
| Piper Sandler | Analyst unavailable | $258 | $227.26 | +88.3% | May 4, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $272 | $227.39 | +98.5% | May 4, 2026 |
| Jefferies | Andrew Tsai | $275 | $227.92 | +100.7% | May 4, 2026 |
| Deutsche Bank | David Hoang | $281 | $227.35 | +105.1% | May 4, 2026 |
| H.C. Wainwright | Raghuram Selvaraju | $270 | $206.53 | +97.1% | May 4, 2026 |
| Oppenheimer | Analyst unavailable | $250 | $201.03 | +82.5% | May 1, 2026 |
| Morgan Stanley | Analyst unavailable | $217 | $207.75 | +58.4% | Apr 30, 2026 |
| UBS | Analyst unavailable | $259 | $179.26 | +89.1% | Apr 10, 2026 |
| RBC Capital | Analyst unavailable | $222 | $168.35 | +62.0% | Feb 24, 2026 |
| UBS | Analyst unavailable | $251 | $170.81 | +83.2% | Feb 24, 2026 |
| Morgan Stanley | Analyst unavailable | $207 | $174.76 | +51.1% | Feb 24, 2026 |
| Guggenheim | Analyst unavailable | $220 | $174.76 | +60.6% | Feb 24, 2026 |
| Wells Fargo | Analyst unavailable | $202 | $174.76 | +47.4% | Feb 24, 2026 |
| Wolfe Research | Rudy Li | $230 | $174.76 | +67.9% | Feb 23, 2026 |
| Truist Financial | Joon Lee | $200 | $173.55 | +46.0% | Feb 23, 2026 |
| Jefferies | Analyst unavailable | $215 | $173.9 | +56.9% | Feb 23, 2026 |
| Mizuho Securities | Analyst unavailable | $230 | $184.74 | +67.9% | Feb 19, 2026 |
| RBC Capital | Leonid Timashev | $219 | $184.5 | +59.9% | Jan 21, 2026 |
| H.C. Wainwright | Analyst unavailable | $260 | $177.27 | +89.8% | Jan 20, 2026 |
| Piper Sandler | Analyst unavailable | $223 | $174.14 | +62.8% | Jan 16, 2026 |
| Robert W. Baird | Analyst unavailable | $209 | $175.98 | +52.6% | Jan 13, 2026 |
| Wells Fargo | Analyst unavailable | $193 | $176.82 | +40.9% | Jan 13, 2026 |
| Morgan Stanley | Analyst unavailable | $204 | $170.69 | +48.9% | Jan 8, 2026 |
| UBS | Analyst unavailable | $248 | $175.14 | +81.0% | Jan 6, 2026 |
| Needham | Ami Fadia | $225 | $178.69 | +64.2% | Jan 5, 2026 |
| H.C. Wainwright | Raghuram Selvaraju | $200 | $178.69 | +46.0% | Jan 5, 2026 |
| Guggenheim | Yatin Suneja | $205 | $179.14 | +49.6% | Jan 2, 2026 |
| Mizuho Securities | Graig Suvannavejh | $217 | $182.86 | +58.4% | Dec 31, 2025 |
| Oppenheimer | Jay Olson | $220 | $182.64 | +60.6% | Dec 31, 2025 |
| H.C. Wainwright | Analyst unavailable | $185 | $134.11 | +35.0% | Nov 4, 2025 |
| RBC Capital | Analyst unavailable | $198 | $133.5 | +44.5% | Nov 4, 2025 |
| Morgan Stanley | Analyst unavailable | $196 | $133.81 | +43.1% | Nov 4, 2025 |
| Wells Fargo | Analyst unavailable | $157 | $135.75 | +14.6% | Nov 4, 2025 |
| Morgan Stanley | Sean Laaman | $194 | $127.94 | +41.6% | Oct 20, 2025 |
| Wells Fargo | Analyst unavailable | $163 | $123.47 | +19.0% | Sep 2, 2025 |
| Robert W. Baird | Joel Beatty | $162 | $112.16 | +18.2% | May 6, 2025 |
| Mizuho Securities | Graig Suvannavejh | $216 | $121.77 | +57.7% | Mar 27, 2025 |
| Robert W. Baird | Analyst unavailable | $160 | $127.15 | +16.8% | Mar 3, 2025 |
| Mizuho Securities | Graig Suvannavejh | $137 | $107.43 | +0.0% | Feb 3, 2025 |
| Truist Financial | Joon Lee | $190 | $107.43 | +38.7% | Feb 3, 2025 |
| Robert W. Baird | Joel Beatty | $132 | $107.43 | -3.6% | Feb 3, 2025 |
| Guggenheim | Yatin Suneja | $135 | $99.49 | -1.5% | Nov 12, 2024 |
| Mizuho Securities | Graig Suvannavejh | $106 | $90.58 | -22.6% | Sep 11, 2024 |
| Wells Fargo | Cerena Chen | $140 | $88.86 | +2.2% | Sep 3, 2024 |
| H.C. Wainwright | Raghuram Selvaraju | $180 | $83.21 | +31.4% | Aug 6, 2024 |
| Bank of America Securities | Jason Gerberry | $106 | $83.93 | -22.6% | Aug 6, 2024 |
| RBC Capital | Leonid Timashev | $131 | $84.85 | -4.4% | Jul 22, 2024 |
| RBC Capital | Leonid Timashev | $130 | $72.24 | -5.1% | Jun 5, 2024 |
| Piper Sandler | David Amsellem | $115 | $75.19 | -16.1% | May 28, 2024 |
| Morgan Stanley | Vikram Purohit | $115 | $74.14 | -16.1% | Apr 29, 2024 |
| Mizuho Securities | Graig Suvannavejh | $109 | $79.17 | -20.4% | Mar 28, 2024 |
| Robert W. Baird | Joel Beatty | $108 | $72.54 | -21.2% | Mar 18, 2024 |
| Piper Sandler | Analyst unavailable | $75 | $73.34 | -45.3% | Jan 5, 2023 |
| BTIG | Robert Hazlett | $98 | $75.13 | -28.5% | Dec 23, 2022 |
| Morgan Stanley | Analyst unavailable | $86 | $74.95 | -37.2% | Nov 29, 2022 |
| Leerink Partners | Analyst unavailable | $85 | $74.74 | -38.0% | Nov 29, 2022 |
| Guggenheim | Analyst unavailable | $80 | $55.48 | -41.6% | Nov 11, 2022 |
| Truist Financial | Joon Lee | $150 | $59.03 | +9.5% | Aug 19, 2022 |
| Mizuho Securities | Analyst unavailable | $49 | $34.04 | -64.2% | May 3, 2022 |
| Morgan Stanley | Analyst unavailable | $27 | $30.59 | -80.3% | Apr 27, 2022 |
| Truist Financial | Joon Lee | $90 | $30.98 | -34.3% | Mar 1, 2022 |
| Bank of America Securities | Ashwani Verma | $25 | $23.78 | -81.8% | Aug 10, 2021 |
Track every rating change on AXSM the moment it posts. Free to start.
Start freeGet the AXSM recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.